Sanofi Consumer Healthcare Inc Stock Price Today (NSE: SANOFICONR)
Fundamental Score
Sanofi Consumer Healthcare Inc Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Sanofi Consumer Healthcare Inc share price today is ₹4753.30, up +0.20% on NSE/BSE as of 17 June 2026. Sanofi Consumer Healthcare Inc (SANOFICONR) is a Mid-cap company in the Pharmaceuticals sector with a market capitalisation of ₹10.65K (Cr). The 52-week high for SANOFICONR share price is ₹5894.50 and the 52-week low is ₹3975.00. At a P/E ratio of 49.57x, SANOFICONR is currently trading above its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 83.81% and a debt-to-equity ratio of 0.11.
Sanofi Consumer Healthcare Inc Share Price Chart — NSE/BSE Historical Performance
Sanofi Consumer Healthcare Inc share price chart: -2.50% return over the past month. 52-week high ₹5894.50, 52-week low ₹3975.00.
Sanofi Consumer Healthcare Inc — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹4668.00 | ₹4686.40 | ₹4491.20 | ₹4529.90 | 8.62K (Cr) | |
| ₹4678.70 | ₹4729.00 | ₹4602.20 | ₹4654.90 | 3.68K (Cr) | |
| ₹4726.50 | ₹4740.50 | ₹4580.00 | ₹4609.60 | 7.01K (Cr) | |
| ₹4715.10 | ₹4780.00 | ₹4692.30 | ₹4735.10 | 3.15K (Cr) | |
| ₹4850.30 | ₹4907.90 | ₹4648.30 | ₹4688.90 | 8.28K (Cr) | |
| ₹4740.00 | ₹4900.00 | ₹4740.00 | ₹4854.40 | 1.65K (Cr) | |
| ₹4802.60 | ₹4843.20 | ₹4760.00 | ₹4789.40 | 2.76K (Cr) | |
| ₹4805.00 | ₹4845.00 | ₹4750.00 | ₹4795.20 | 4.00K (Cr) | |
| ₹4980.00 | ₹4980.00 | ₹4801.00 | ₹4868.40 | 4.12K (Cr) | |
| ₹4609.10 | ₹5255.00 | ₹4609.10 | ₹5026.80 | 40.78K (Cr) |
Sanofi Consumer Healthcare Inc — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹4760.00 | ₹5255.00 | ₹4491.20 | ₹4529.90 | -4.83% | |
| ₹4350.00 | ₹4955.60 | ₹4302.20 | ₹4763.90 | +9.51% | |
| ₹4354.50 | ₹4609.80 | ₹4000.50 | ₹4298.20 | -1.29% | |
| ₹4287.80 | ₹4811.00 | ₹3975.00 | ₹4489.30 | +4.70% | |
| ₹4479.40 | ₹4605.60 | ₹3990.00 | ₹4246.80 | -5.19% | |
| ₹4699.70 | ₹4874.10 | ₹4382.20 | ₹4519.90 | -3.83% | |
| ₹4900.00 | ₹5078.00 | ₹4592.30 | ₹4659.70 | -4.90% | |
| ₹4767.70 | ₹4899.00 | ₹4556.00 | ₹4842.60 | +1.57% | |
| ₹5133.50 | ₹5357.00 | ₹4701.00 | ₹4720.50 | -8.05% | |
| ₹4901.00 | ₹5512.00 | ₹4728.00 | ₹5185.40 | +5.80% | |
| ₹5696.00 | ₹5696.00 | ₹4873.00 | ₹4908.00 | -13.83% | |
| ₹5078.50 | ₹5894.50 | ₹4935.00 | ₹5696.00 | +12.16% |
AI Research Briefing
Powered by Gemini · 2026-04-09
Overvalued consumer healthcare play with limited upside at current multiples.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search. Last significant news was FY25 results. Sanofi Consumer Healthcare India reported a 33% jump in FY25 profit on 21% revenue growth. Q4 net profit jumped 50.11% to , with total income increasing by 45.48% to
CORE STORY (THE REAL GAME)
- Strong Q4 & FY25 results
- Dividend payout
- Overall India Pharma Growth
- Significant earnings beat
- New product launches with strong market reception
- Decrease in valuation multiples
- Rich valuation (P/E of 49.57x vs. industry P/E of 31.77x)
- FII selling (-0.3%)
- Reliance on a few key brands
FII decreased holdings by 0.3%.
Indian pharmaceutical sector is projected to grow to $130 billion by 2030, but US market headwinds could dent earnings.
Free Cash Flow 5Y: ₹None Cr
Expect moderate growth in the next 3-6 months. Valuation is a concern. Monitor for any slowdown in growth or margin compression.
Primary Thesis Risk
Valuation is stretched, leaving little margin of safety.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Sanofi Consumer Healthcare Inc Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Sanofi Consumer Healthcare Inc Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SANOFICONR across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Strong Return on Equity (83.81%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (111.44%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Robust Profit Growth (37.13%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (46.28%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Conservative Debt Levels (D/E: 0.11)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (153.05x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (71.27%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
Premium Valuation Risk (P/E: 49.57x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Sanofi Consumer Healthcare Inc vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Sanofi Consumer Healthcare Inc with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Sanofi Consumer Healthcare IncSanofi Consumer...Selected✓ SANOFICONR • 544250 | 51.2/100 | ₹4753.30₹4753 | ₹10651.74₹10651.74 | 49.57Average 49.6 Average | 83.81%Excellent 83.81% Excellent | 111.44%Excellent 111.44% Excellent | 0.11Excellent 0.1 Excellent | — — | — — | 1.19% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1796.50₹1797 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6553.50₹6554 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4350.40₹4350 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1390.30₹1390 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1290.40₹1290 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2262.90₹2263 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹1091.20₹1091 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2320.20₹2320 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1433.70₹1434 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5314.50₹5315 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
Sanofi Consumer Healthcare Inc PE Ratio History
Historical price-to-earnings ratio for SANOFICONR — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹78.59 | ₹4927.40 | 62.7x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Sanofi Consumer Healthcare Inc Dividend History
Annual cash dividends paid by SANOFICONR — dividend yield 1.19%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2024 | ₹115.20 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Sanofi Consumer Healthcare Inc Quarterly Performance
Latest quarterly metrics for SANOFICONR — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
46.28%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
37.13%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Sanofi Consumer Healthcare Inc Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SANOFICONR — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Sanofi Consumer Healthcare Inc Financial Statements
Annual income statement, balance sheet and cash flow for Sanofi Consumer Healthcare Inc (SANOFICONR) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Sanofi Consumer Healthcare Inc
About SANOFICONR (Sanofi Consumer Healthcare Inc)
Sanofi Consumer Healthcare Inc. is a dynamic player in the global over-the-counter (OTC) pharmaceutical landscape, dedicated to empowering individuals to proactively manage their h...ealth and well-being. With a commitment to scientific innovation and consumer-centric solutions, the company develops, manufactures, and markets a diverse portfolio of trusted brands. These brands address a broad spectrum of everyday health needs, including digestive health, pain management, allergy relief, cough, cold, and flu remedies, as well as vitamins, minerals, and supplements. Sanofi Consumer Healthcare Inc. operates with a vision to be a reliable partner in self-care, making quality healthcare accessible and convenient for consumers worldwide. Leveraging cutting-edge research and development, Sanofi Consumer Healthcare Inc. continuously strives to enhance its existing product lines and introduce innovative solutions to meet evolving consumer demands. The company's product development strategy is driven by a deep understanding of consumer needs and preferences, coupled with a commitment to rigorous scientific testing and adherence to the highest quality standards. Through strategic partnerships and acquisitions, Sanofi Consumer Healthcare Inc. expands its reach and reinforces its position as a leader in the consumer healthcare industry. The company prides itself on fostering a culture of innovation and collaboration, attracting top talent and nurturing a passion for improving people's lives. Sanofi Consumer Healthcare Inc.'s distribution network spans across multiple channels, including retail pharmacies, supermarkets, drug stores, and e-commerce platforms, ensuring convenient access to its products for consumers across diverse demographics. The company invests significantly in marketing and educational initiatives to raise awareness about its brands and empower consumers to make informed choices about their health. With a strong emphasis on ethical and responsible business practices, Sanofi Consumer Healthcare Inc. is dedicated to building long-term relationships with its customers, partners, and stakeholders, contributing to the overall well-being of communities around the globe. The company's commitment extends beyond providing effective healthcare solutions; it encompasses a dedication to sustainability and corporate social responsibility.
Company Details
Key Leadership
Corporate Events
SANOFICONR Share Price: Frequently Asked Questions
What is the current share price of Sanofi Consumer Healthcare Inc?
Sanofi Consumer Healthcare Inc (SANOFICONR) trades at ₹4753.30 on NSE and BSE. Market cap ₹10.65K (Cr). Educational data only.
What is the P/E ratio of Sanofi Consumer Healthcare Inc?
Sanofi Consumer Healthcare Inc has a P/E of 49.57x vs industry average 31.77x.
What is the Bull Run score for Sanofi Consumer Healthcare Inc?
Sanofi Consumer Healthcare Inc has a Bull Run score of 51.2/100 based on 25+ financial parameters.
Does Sanofi Consumer Healthcare Inc pay dividends?
Sanofi Consumer Healthcare Inc has a dividend yield of 1.19%. Past dividends don't guarantee future payments.
What is the ROE of Sanofi Consumer Healthcare Inc?
Sanofi Consumer Healthcare Inc has ROE of 83.81%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Sanofi Consumer Healthcare Inc?
Sanofi Consumer Healthcare Inc has debt-to-equity of 0.11.
Is Sanofi Consumer Healthcare Inc a good investment?
Bull Run gives Sanofi Consumer Healthcare Inc a score of 51.2/100. This is not investment advice — consult a SEBI-registered advisor.